AGRX
Agile Therapeutics, Inc
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
45 hedge funds and large institutions have $65.5M invested in Agile Therapeutics, Inc in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
-2
Holders Change %
-4.26%
% of All Funds
1.02%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
11
Increased
16
Reduced
8
Closed
13
Calls
$288K
Puts
$16K
Net Calls
+$272K
Net Calls Change
+$215K
Top Buyers
1 |
PA
Perceptive Advisors
New York
|
$9.09M |
2 |
BC
Broadfin Capital
New York
|
$964K |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
$2.67M |
4 |
Renaissance Technologies
New York
|
$985K |
5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$838K |